About Retractable Technologies
Retractable Technologies is a company based in Little Elm (United States) founded in 1989 by Thomas Shaw.. The company has 227 employees as of December 31, 2024. Retractable Technologies offers products and services including VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter. Retractable Technologies operates in a competitive market with competitors including Owen Mumford, Flat Medical, Stable Pharma, KORU Medical Systems and NuGen MD, among others.
- Headquarter Little Elm, United States
- Employees 227 as on 31 Dec, 2024
- Founders Thomas Shaw
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Retractable Technologies, Inc.
-
Annual Revenue
$33.05 M-24.19as on Dec 31, 2024
-
Net Profit
$-11.89 M-69.54as on Dec 31, 2024
-
EBITDA
$-13.54 M-241.72as on Dec 31, 2024
-
Latest Funding Round
$27.37 M (USD), Grant
Jul 01, 2020
- Investors
-
Employee Count
227
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Retractable Technologies
Retractable Technologies is a publicly listed company on the AMEX with ticker symbol RVP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Retractable Technologies
Retractable Technologies offers a comprehensive portfolio of products and services, including VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Retractable syringe that prevents needlestick injuries during injections.
Needle designed for safe blood collection and reduced injury risk.
Specialized syringe for insulin with low dead space to minimize waste.
Tube with needle for secure blood sampling and safety features.
Catheter that ensures safe intravenous access and injury prevention.
Funding Insights of Retractable Technologies
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $27.4M
-
First Round
First Round
(01 Jul 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Grant - Retractable Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Retractable Technologies
Retractable Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include USAGov. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entity focused on information and services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Retractable Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Retractable Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Retractable Technologies Comparisons
Competitors of Retractable Technologies
Retractable Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owen Mumford, Flat Medical, Stable Pharma, KORU Medical Systems and NuGen MD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Disposables for drug delivery and capillary blood sampling are manufactured.
|
|
| domain | founded_year | HQ Location |
Epidural injection syringes with pressure detection are manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of technology to store and deliver stable drugs and vaccines
|
|
| domain | founded_year | HQ Location |
Infusion systems and accessories for subcutaneous drug administration are manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of needle-free drug delivery system
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Retractable Technologies
Frequently Asked Questions about Retractable Technologies
When was Retractable Technologies founded?
Retractable Technologies was founded in 1989 and raised its 1st funding round 31 years after it was founded.
Where is Retractable Technologies located?
Retractable Technologies is headquartered in Little Elm, United States. It is registered at Little Elm, Texas, United States.
Who is the current CEO of Retractable Technologies?
Thomas Shaw is the current CEO of Retractable Technologies. They have also founded this company.
How many employees does Retractable Technologies have?
As of Dec 31, 2024, the latest employee count at Retractable Technologies is 227.
What is the annual revenue of Retractable Technologies?
Annual revenue of Retractable Technologies is $33.05M as on Dec 31, 2024.
What does Retractable Technologies do?
Retractable Technologies was founded in 1989 and is headquartered in Little Elm, United States. Focus is placed on the medical device sector, where safety products are developed for healthcare applications. VanishPoint Syringes are offered in multiple sizes, gauges, and lengths, with needles retracting automatically into the barrel upon plunger depression. EasyPoint retractable needles are also included, featuring automated technology for pre-removal safety to reduce injury risks.
Who are the top competitors of Retractable Technologies?
Retractable Technologies's top competitors include KORU Medical Systems, Stable Pharma and Flat Medical.
What products or services does Retractable Technologies offer?
Retractable Technologies offers VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter.
Is Retractable Technologies publicly traded?
Yes, Retractable Technologies is publicly traded on AMEX under the ticker symbol RVP.
Who are Retractable Technologies's investors?
Retractable Technologies has 1 investor. Key investors include USAGov.
What is Retractable Technologies's ticker symbol?
The ticker symbol of Retractable Technologies is RVP on AMEX.